Author: Jana Garrett

Precigen, Inc. (Nasdaq: PGEN), a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the lives of patients, today announced the Company will release full year 2025 financial results and provide business updates on Wednesday, March 25, 2026. The Company will host a conference call to discuss results that day at 4:30 PM ET.Read More

Read More

The Department of Health started to “operationalize” Wednesday morning, preparing an emergency rule to return income eligibility for the AIDS Drug Assistance Program (ADAP) to 400% of the federal poverty, an attorney for the health department said. DOH outside attorney Eduardo Lombard told Leon County Circuit Court Judge Judge Jonathan Sjostrom Wednesday that the department […]Read More

Read More